- Albrecht to chair the Board Actavis today announced it has successfully agreed a debt refinancing in collaboration with its lenders. The refinancing gives Actavis a capital structure

Actavis today announced that it has received approval from the FDA to market Bupropion HCl Extended-Release (SR) tablets 100mg and 200mg. Distribution of the product will commence immediately.

Actavis has launched Valaciclovir in Switzerland on day one after the patent expired on 27 June. Valaciclovir is used to treat herpes virus infections. Valaciclovir Actavis has already been